Page last updated: 2024-08-18

cyclohexanol and Attention Deficit Disorder with Hyperactivity

cyclohexanol has been researched along with Attention Deficit Disorder with Hyperactivity in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's10 (38.46)18.2507
2000's10 (38.46)29.6817
2010's6 (23.08)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ago, Y; Fujita, K; Hiramatsu, N; Kawanai, T; Matsuda, T; Takuma, K; Umehara, M1
Caballero, J; Omidian, H; Park, P1
Vitiello, B1
Akhondzadeh, S; Hazrati, N; Mohammadi, MR; Rezaie, F; Rezazadeh, SA; Tabrizi, M; Zarinara, AR1
Filatova, EG; Latysheva, NV; Naprienko, MV1
Amiri, S; Farhang, S; Ghoreishizadeh, MA; Malek, A; Mohammadzadeh, S1
Berk, M; Freeman, RD; Ghanizadeh, A1
Maidment, ID1
Abali, O; Mukaddes, NM1
Bertschy, G; Carminati, GG; Deriaz, N1
Heerdink, ER; van Dijk, L; Volkers, AC1
Aharonovich, E; Bisaga, A; Brooks, DJ; Garawi, F; Levin, FR; Mariani, J; Nunes, EV; Raby, W; Rubin, E1
Demeter, CA; Findling, RL; Greenhill, LL; Kotler, LA; McNamara, NK; Myers, C; O'Riordan, MA; Reed, MD1
Gormly, LJ; Pleak, RR1
Biederman, J; Spencer, TJ; Wilens, TE1
Findling, RL; Flannery, DJ; Manos, MJ; Schwartz, MA1
Hedges, D; Reimherr, FW; Rogers, A; Strong, R; Wender, PH1
Adler, LA; Devinsky, O; Kunz, M; Resnick, S1
Smith, MN1
Luh, J; Olvera, RL; Pliszka, SR; Tatum, R1
Dogin, JW; Findling, RL1
Hornig, M1
Chong, Y; Harris, R; Kim, WJ1
Ninan, PT1
Brady, KT; Malcolm, R; Sethuraman, G; Sonne, SC; Upadhyaya, HP1
Amsterdam, JD; Hornig-Rohan, M1

Reviews

6 review(s) available for cyclohexanol and Attention Deficit Disorder with Hyperactivity

ArticleYear
Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Duloxetine Hydrochloride; Humans; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Thiophenes; Venlafaxine Hydrochloride

2014
Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.
    Reviews on recent clinical trials, 2013, Volume: 8, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clinical Trials as Topic; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Methylphenidate; Research Design; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

2013
The use of antidepressants to treat attention deficit hyperactivity disorder in adults.
    Journal of psychopharmacology (Oxford, England), 2003, Volume: 17, Issue:3

    Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Bupropion; Clinical Trials as Topic; Cyclohexanols; Humans; Propylamines; Venlafaxine Hydrochloride

2003
Psychopharmacology of ADHD: children and adolescents.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1998
Addressing comorbidity in adults with attention-deficit/hyperactivity disorder.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 7

    Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Clinical Trials as Topic; Comorbidity; Cyclohexanols; Dopamine; Dopamine Antagonists; Epinephrine; Humans; Mental Disorders; Norepinephrine; Prevalence; Psychotropic Drugs; Serotonin; Venlafaxine Hydrochloride

1998
Use of venlafaxine in other psychiatric disorders.
    Depression and anxiety, 2000, Volume: 12 Suppl 1

    Topics: Anxiety; Attention Deficit Disorder with Hyperactivity; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fibromyalgia; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Phobic Disorders; Selective Serotonin Reuptake Inhibitors; Trichotillomania; Venlafaxine Hydrochloride

2000

Trials

10 trial(s) available for cyclohexanol and Attention Deficit Disorder with Hyperactivity

ArticleYear
Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
    Human psychopharmacology, 2010, Volume: 25, Issue:7-8

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Methylphenidate; Outpatients; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride

2010
Double-blind controlled trial of venlafaxine for treatment of adults with attention deficit/hyperactivity disorder.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2012
Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.
    Psychiatry and clinical neurosciences, 2004, Volume: 58, Issue:1

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Female; Humans; Male; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride

2004
Effects of major depressive disorder and attention-deficit/hyperactivity disorder on the outcome of treatment for cocaine dependence.
    Journal of substance abuse treatment, 2008, Volume: 34, Issue:1

    Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cocaine-Related Disorders; Cyclohexanols; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate; Retention, Psychology; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

2008
Venlafaxine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder.
    Journal of child and adolescent psychopharmacology, 2007, Volume: 17, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Faculty; Female; Humans; Male; Norepinephrine; Parents; Pilot Projects; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Serotonin; Severity of Illness Index; Venlafaxine Hydrochloride

2007
Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:5

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Psychometrics; Research Design; Treatment Outcome; Venlafaxine Hydrochloride

1996
An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride

1995
Open-label trial of venlafaxine in adults with attention deficit disorder.
    Psychopharmacology bulletin, 1995, Volume: 31, Issue:4

    Topics: Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride

1995
An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents.
    Journal of child and adolescent psychopharmacology, 1996,Winter, Volume: 6, Issue:4

    Topics: Adolescent; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interviews as Topic; Male; Parents; Psychiatric Status Rating Scales; Psychological Tests; Reaction Time; Venlafaxine Hydrochloride

1996
Venlafaxine treatment of patients with comorbid alcohol/cocaine abuse and attention-deficit/hyperactivity disorder: a pilot study.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Alcoholism; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Cocaine-Related Disorders; Comorbidity; Cyclohexanols; Humans; Middle Aged; Pilot Projects; Treatment Outcome; Venlafaxine Hydrochloride

2001

Other Studies

10 other study(ies) available for cyclohexanol and Attention Deficit Disorder with Hyperactivity

ArticleYear
Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.
    Behavioural pharmacology, 2013, Volume: 24, Issue:4

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exploratory Behavior; Male; Methylphenidate; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar; Receptors, Adrenergic, alpha-2; Time Factors; Venlafaxine Hydrochloride

2013
Recent NIMH clinical trials and implications for practice.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2008, Volume: 47, Issue:12

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride

2008
[New approaches to the treatment of chronic daily headache].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:9

    Topics: Adult; Aminopyridines; Analgesics; Attention Deficit Disorder with Hyperactivity; Constipation; Cyclohexanols; Diarrhea; Female; Headache Disorders; Humans; Male; Nausea; Pain Threshold; Treatment Outcome; Venlafaxine Hydrochloride

2010
Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms.
    Progress in neuro-psychopharmacology & biological psychiatry, 2006, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Cyclohexanols; Female; Follow-Up Studies; Humans; Male; Self-Injurious Behavior; Time Factors; Venlafaxine Hydrochloride

2006
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
    Pharmacoepidemiology and drug safety, 2007, Volume: 16, Issue:9

    Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride

2007
Effects of venlafaxine treatment for ADHD in a child.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Cyclohexanols; Female; Humans; Hypertension; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

1995
Venlafaxine for adult ADHD.
    The American journal of psychiatry, 1995, Volume: 152, Issue:7

    Topics: Age Factors; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Female; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride

1995
Pharmacologic properties of venlafaxine.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:4

    Topics: Adrenergic Uptake Inhibitors; Adult; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Dopamine Uptake Inhibitors; Humans; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1997
Dystonia as a side effect of nonneuroleptics.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1999, Volume: 38, Issue:7

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Cyclohexanols; Drug Interactions; Dystonia; Fluoxetine; Guanfacine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Suicide, Attempted; Venlafaxine Hydrochloride

1999
Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression.
    Progress in neuro-psychopharmacology & biological psychiatry, 2002, Volume: 26, Issue:3

    Topics: Adult; Aged; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Chi-Square Distribution; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Venlafaxine Hydrochloride

2002